Dianal Calcium PD 1.5%

Adult dosage

In adults, infuse 1.5 to 2.5L into the abdominal cavity at a time, allowing it to dwell for 4 to 8 hours before draining, performed 3 to 5 times daily.

This medication is a solution for peritoneal dialysis, used to remove waste and excess fluids from the body through the peritoneum. Caution is necessary as premature discontinuation of peritoneal dialysis can be life-threatening if there are no alternative renal replacement therapies available. This medication should not be used in certain patients. For example, patients with a diaphragmatic defect may experience respiratory distress if the dialysis solution moves into the thoracic cavity. It should not be administered to patients with abdominal burns or severe peritoneal adhesions, as this may reduce dialysis efficiency or interfere with treatment. Patients with a bleeding tendency, suspected lactic acidosis, severe electrolyte imbalances, or those who have had recent abdominal surgery or trauma should also refrain from using this medication. Contraindications include patients with inflammatory bowel disease, abdominal fistulas, intra-abdominal tumors, abdominal hernias, bowel obstructions, severe pulmonary diseases, sepsis, and severe lipid metabolism disorders. Additionally, it should not be used in patients who are unable to perform peritoneal dialysis properly. Certain patients require cautious administration. If taking digitalis preparations, regular testing of serum potassium levels is necessary; and patients suspected of having glucose metabolism disorders should frequently monitor blood glucose levels. Patients with lumbar disorders, those using colostomies, taking diuretics, severe ventilatory issues, severe obesity, immunodeficiency states, pregnant women, and those with peritonitis should also be used with caution. Adverse reactions may occur at the injection site, such as pain, bleeding, inflammation, or peritonitis; symptoms involving the gastrointestinal system or electrolyte imbalances, metabolic disorders, or respiratory issues may also occur. Long-term use may lead to reduced peritoneal function, thus regular evaluation by healthcare professionals is necessary. Peritoneal dialysis solutions should be handled in aseptic conditions and used in a clean environment to reduce the risk of infection. It is crucial to always monitor the clarity of the dialysis solution and the amount of drainage, and to immediately report any unusual signs to healthcare professionals. Safety for pregnant and breastfeeding women has not been established, so careful consideration of necessity and risks is needed when using this medication. Dosing for children should be adjusted according to their age and weight, and caution is required in the elderly due to increased risk of hernia. In cases of overdose, side effects such as dehydration, electrolyte imbalances, or hyperglycemia may occur, necessitating immediate treatment. Peritoneal dialysis solutions should be used in the original container, and if the packaging is damaged or the solution is cloudy, it should not be used. Always check the condition of the container before use, and this solution is intended solely for peritoneal dialysis, not for IV use. The dialysis solution should be warmed to body temperature and the remaining solution should not be reused. When adding medications, use a sterile single-use syringe, and use it immediately after addition.

Serious side effects

Peritonitis (abdominal pain, cloudy drainage fluid, sometimes accompanied by fever), bowel obstruction, respiratory distress due to diaphragmatic defects, sepsis, pulmonary edema, pleural effusion, edema, severe edema or edema accompanied by elevated blood pressure

Mild side effects

Abdominal pain, bleeding, peritonitis, inflammation around the abdominal catheter, catheter breakage or drainage difficulties, nausea, abdominal pain, diarrhea, constipation, hemorrhoids, vomiting, loss of appetite, abdominal bloating, hypokalemia, hyponatremia, hypercalcemia, hypophosphatemia, hyperlactatemia, hypomagnesemia, hypercholesterolemia, hypertriglyceridemia, metabolic acidosis, hypoproteinemia, hyperglycemia, pulmonary edema, pleural effusion, edema, shoulder pain, fever, muscle cramps

This medication should be stored in a sealed container to prevent exposure to air, and it is crucial to maintain storage temperatures between 1 and 30 degrees Celsius. Therefore, it is advisable to keep it away from direct sunlight and avoid placing it in areas that are too hot or too cold.

Appearance

It is a colorless, transparent liquid packaged in a transparent polyvinyl chloride bag that has a light yellow tint and is sealed. 2L/2 bags (for continuous ambulatory peritoneal dialysis) include injection lines, inner plugs, clamps, Y-connectors, and a cover.

Package unit

2000ml/2 bags